XML 33 R21.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Financial Instruments | 3 Months Ended
--- | ---
Mar. 31, 2018
Fair Value Disclosures [Abstract] |
Financial Instruments | Financial Instruments Debt Instruments The carrying values of the Company’s debt instruments vary from their fair values. The fair values were determined by reference to the quoted market prices of these securities (Level 2 input based on the GAAP fair value hierarchy). The estimated fair value, as well as the carrying value, of the Company's debt instruments are shown below (in millions):
| March 31, 2018 |  | December 31, 2017
Estimated aggregate fair value (1) | $ | 1,994.8 |  |  | $ | 2,033.5 |
Aggregate carrying value (1) (2) | 1,971.9 |  |  | 1,973.4 |
(1) Credit agreement and senior notes (excludes "other" debt) (2) Excludes the impact of unamortized original issue discount and debt issuance costs Cash, Cash Equivalents and Restricted Cash On January 1, 2018, the Company adopted ASU 2016-18, "Restricted Cash." The new standard requires that changes in restricted cash be reflected with changes in cash and cash equivalents on the statement of cash flows and that a reconciliation between cash and cash equivalents presented on the balance sheet and to cash, cash equivalents and restricted cash presented on the statement of cash flows be provided. The provisions of the standard were applied retrospectively, and the effects of adoption were not significant. The Company has on deposit with banks cash that is legally restricted as to use or withdrawal. A reconciliation of cash, cash equivalents and restricted cash reported on the condensed consolidated balance sheets to cash, cash equivalents and restricted cash reported on the condensed consolidated statements of cash flows is shown below (in millions):
| March 31, 2018 |  | April 1, 2017
Balance sheet - cash and cash equivalents | $ | 1,268.5 |  |  | $ | 1,209.7 |
Restricted cash included in other current assets | 8.4 |  |  | — |
Restricted cash included in other long-term assets | 17.6 |  |  | — |
Statement of cash flows - cash, cash equivalents and restricted cash | $ | 1,294.5 |  |  | $ | 1,209.7 |
Marketable Equity Securities Marketable equity securities, which the Company accounts for under the fair value option, are included in the accompanying condensed consolidated balance sheets as shown below (in millions):
| March 31, 2018 |  | December 31, 2017
Current assets | $ | — |  |  | $ | 3.2 |
Other long-term assets | 45.6 |  |  | 40.6 |
| $ | 45.6 |  |  | $ | 43.8 |
Unrealized gains and losses arising from changes in the fair value of the marketable equity securities are recognized in the accompanying condensed consolidated statement of comprehensive income as a component of other (income) expense, net. The fair value of the marketable equity securities is determined by reference to quoted market prices in active markets (Level 1 input based on the GAAP fair value hierarchy). Derivative Instruments and Hedging Activities The Company has used derivative financial instruments, including forwards, futures, options, swaps and other derivative contracts to reduce the effects of fluctuations in foreign exchange rates and interest rates and the resulting variability of the Company’s operating results. The Company is not a party to leveraged derivatives. The Company’s derivative financial instruments are subject to master netting arrangements that provide for the net settlement of contracts, by counterparty, in the event of default or termination. On the date that a derivative contract for a hedging instrument is entered into, the Company designates the derivative as either (1) a hedge of the exposure to changes in the fair value of a recognized asset or liability or of an unrecognized firm commitment (a fair value hedge), (2) a hedge of the exposure of a forecasted transaction or of the variability in the cash flows of a recognized asset or liability (a cash flow hedge), (3) a hedge of a net investment in a foreign operation (a net investment hedge) or (4) a contract not designated as a hedging instrument. For a fair value hedge, the change in the fair value of the derivative is recorded in earnings and reflected in the condensed consolidated statement of comprehensive income on the same line as the gain or loss on the hedged item attributable to the hedged risk. For a cash flow hedge, the change in the fair value of the derivative is recorded in accumulated other comprehensive loss in the condensed consolidated balance sheet. When the underlying hedged transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings and reflected in the condensed consolidated statement of comprehensive income on the same line as the gain or loss on the hedged item attributable to the hedged risk. For a net investment hedge, the change in the fair value of the derivative is recorded in cumulative translation adjustment, which is a component of accumulated other comprehensive loss in the condensed consolidated balance sheet. Changes in the fair value of contracts not designated as hedging instruments are recorded in earnings and reflected in the condensed consolidated statement of comprehensive income as other expense, net. On January 1, 2018, the Company early adopted ASU 2017-12, "Targeted Improvements to Accounting for Hedging Activities." The new standard eliminates the requirement to separately measure and report hedge ineffectiveness, due to a difference between the economic terms of the hedge instrument and the underlying transaction, and generally requires, for qualifying hedges, the entire change in the fair value of a hedging instrument to be presented in the same line as the hedged item in the condensed consolidated statement of comprehensive income. The standard also modifies the accounting for components excluded from the assessment of hedge effectiveness and simplifies the application of hedge accounting in certain situations. The provisions of the standard were applied on a modified retrospective basis, and the effects of adoption were not significant. Foreign Exchange The Company uses forwards, swaps and other derivative contracts to reduce the effects of fluctuations in foreign exchange rates on known foreign currency exposures. Gains and losses on the derivative instruments are intended to offset gains and losses on the hedged transaction in an effort to reduce exposure to fluctuations in foreign exchange rates. The principal currencies hedged by the Company include the Mexican peso, various European currencies, the Thai baht, the Japanese yen, the Chinese renminbi and the Philippine peso. The notional amount, estimated fair value and related balance sheet classification of the Company's foreign currency derivative contracts are shown below (in millions, except for maturities):
| March 31, 2018 |  | December 31, 2017
Fair value of foreign currency contracts designated as cash flow hedges: |  |  |
Other current assets | $ | 39.4 |  |  | $ | 16.9 |
Other long-term assets | 6.4 |  |  | 1.3 |
Other current liabilities | (15.5 | ) |  | (28.4 | )
Other long-term liabilities | (0.7 | ) |  | (8.0 | )
| 29.6 |  |  | (18.2 | )
Notional amount | $ | 1,408.0 |  |  | $ | 1,538.5 |
Outstanding maturities in months, not to exceed | 24 |  |  | 24 |
Fair value of foreign currency contracts not designated as hedging instruments: |  |  |
Other current assets | $ | 6.5 |  |  | $ | 1.8 |
Other current liabilities | (5.0 | ) |  | (6.4 | )
| 1.5 |  |  | (4.6 | )
Notional amount | $ | 1,229.9 |  |  | $ | 681.1 |
Outstanding maturities in months, not to exceed | 9 |  |  | 12 |
Total fair value | $ | 31.1 |  |  | $ | (22.8 | )
Total notional amount | $ | 2,637.9 |  |  | $ | 2,219.6 |
Foreign currency derivative contracts not designated as hedging instruments consist principally of hedges of cash transactions, intercompany loans and certain other balance sheet exposures. Accumulated Other Comprehensive Loss - Derivative Instruments and Hedging Pretax amounts related to foreign currency derivative contracts designated as cash flow hedges that were recognized in and reclassified from accumulated other comprehensive loss are shown below (in millions):
| Three Months Ended
| March 31, 2018 |  | April 1, 2017
Gains recognized in accumulated other comprehensive loss: | $ | 50.9 |  |  | $ | 58.1 |
(Gains) losses reclassified from accumulated other comprehensive loss to: |  |  |
Net sales | 1.7 |  |  | 0.1 |
Cost of sales | (4.8 | ) |  | 11.7 |
| (3.1 | ) |  | 11.8 |
Comprehensive income | $ | 47.8 |  |  | $ | 69.9 |
As of March 31, 2018 and December 31, 2017, pretax net gains (losses) of approximately $29.6 million and ($18.2) million, respectively, related to the Company’s derivative instruments and hedging activities were recorded in accumulated other comprehensive loss. During the next twelve month period, the Company expects to reclassify into earnings net gains of approximately $24.0 million recorded in accumulated other comprehensive loss as of March 31, 2018. Such gains will be reclassified at the time that the underlying hedged transactions are realized. Fair Value Measurements GAAP provides that fair value is an exit price, defined as a market-based measurement that represents the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. Fair value measurements are based on one or more of the following three valuation techniques:
Market: |  | This approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
Income: |  | This approach uses valuation techniques to convert future amounts to a single present value amount based on current market expectations.
Cost: |  | This approach is based on the amount that would be required to replace the service capacity of an asset (replacement cost).
Further, GAAP prioritizes the inputs and assumptions used in the valuation techniques described above into a three-tier fair value hierarchy as follows:
Level 1: |  | Observable inputs, such as quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date.
Level 2: |  | Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.
Level 3: |  | Unobservable inputs that reflect the entity’s own assumptions about the exit price of the asset or liability. Unobservable inputs may be used if there is little or no market data for the asset or liability at the measurement date.
The Company discloses fair value measurements and the related valuation techniques and fair value hierarchy level for its assets and liabilities that are measured or disclosed at fair value. Items Measured at Fair Value on a Recurring Basis Fair value measurements and the related valuation techniques and fair value hierarchy level for the Company’s assets and liabilities measured at fair value on a recurring basis as of March 31, 2018 and December 31, 2017, are shown below (in millions):
| March 31, 2018
| Frequency |  | Asset (Liability) |  | Valuation Technique |  | Level 1 |  | Level 2 |  | Level 3
Foreign currency derivative contracts, net | Recurring |  | $ | 31.1 |  |  | Market/ Income |  | $ | — |  |  | $ | 31.1 |  |  | $ | — |
Marketable equity securities | Recurring |  | $ | 45.6 |  |  | Market |  | $ | 45.6 |  |  | $ | — |  |  | $ | — |
| December 31, 2017
| Frequency |  | Asset (Liability) |  | Valuation Technique |  | Level 1 |  | Level 2 |  | Level 3
Foreign currency derivative contracts, net | Recurring |  | $ | (22.8 | ) |  | Market/ Income |  | $ | — |  |  | $ | (22.8 | ) |  | $ | — |
Marketable equity securities | Recurring |  | $ | 43.8 |  |  | Market |  | $ | 43.8 |  |  | $ | — |  |  | $ | — |
The Company determines the fair value of its derivative contracts using quoted market prices to calculate the forward values and then discounts such forward values to the present value. The discount rates used are based on quoted bank deposit or swap interest rates. If a derivative contract is in a net liability position, the Company adjusts these discount rates, if required, by an estimate of the credit spread that would be applied by market participants purchasing these contracts from the Company’s counterparties. If an estimate of the credit spread is required, the Company uses significant assumptions and factors other than quoted market rates, which would result in the classification of its derivative liabilities within Level 3 of the fair value hierarchy. As of March 31, 2018 and December 31, 2017, there were no derivative contracts that were classified within Level 3 of the fair value hierarchy. In addition, there were no transfers in or out of Level 3 of the fair value hierarchy in 2018. Items Measured at Fair Value on a Non-Recurring Basis The Company measures certain assets and liabilities at fair value on a non-recurring basis, which are not included in the table above. As these non-recurring fair value measurements are generally determined using unobservable inputs, these fair value measurements are classified within Level 3 of the fair value hierarchy. In 2018, as a result of the Lear FAWSN transaction, Level 3 fair value estimates of $10.5 million related to property, plant and equipment, $7.5 million related to intangible assets and $14.0 million of noncontrolling interests are recorded in the accompanying condensed consolidated balance sheet as of March 31, 2018. In addition, the Lear FAWSN transaction required a Level 3 fair value estimate related to the Company's previously held equity interest of $23.0 million. These Level 3 fair value estimates were determined as of the effective date of the transaction. Fair value estimates of property, plant and equipment were based on independent appraisals, giving consideration to the highest and best use of the assets. Key assumptions used in the appraisals were based on a combination of market and cost approaches, as appropriate. Fair value estimates of customer-based intangible assets were based on the present value of future earnings attributable to the asset group after recognition of required returns to other contributory assets. Fair value estimates of noncontrolling and equity interests were based on the present value of future cash flows and a value to earnings multiple approach and reflect discounts for the lack of control and the lack of marketability associated with noncontrolling and equity interests. As of March 31, 2018, there were no additional significant assets or liabilities measured at fair value on a non-recurring basis. For further information related to assets and liabilities measured at fair value on a non-recurring basis, see Note 5, "Long-Term Assets."

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration